US9868777B2
University of Texas System
FIELD OF INVENTION The present invention relates to anti-CMV antigen binding proteins including, but not limited to, monoclonal antibodies. The invention also relates to use of the antigen binding proteins of the present invention in the diagnosis, treatment and/or prevention of CMV infection.